Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

Loop Stefano Sainas

DHODH and cancer: promising prospects to be explored, Cancer & Metabolism

MEDS433 induces apoptosis in several AML cell lines (II). (A) MEDS433

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

DD1 is a Proteasome Inhibitor Used for Acute Myeloid Leukemia (AML) Research

Molecules, Free Full-Text

Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies - ScienceDirect

PDF) Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a ]pyridine Scaffold: SAR of the Aryloxyaryl Moiety

DHODH and cancer: promising prospects to be explored, Cancer & Metabolism

Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor - Alberti - 2023 - FEBS Letters - Wiley Online Library